Brunn Carsten
President and CEO
Brunn Carsten has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jan 8, 2026.
On the most recent filing, Brunn Carsten is listed as President and CEO at Cartesian Therapeutics, Inc. Inside the rolling window, Brunn Carsten reported no open-market purchases and 1 open-market sale totaling $162K in RNAC.
Companies traded
Other insiders at RNAC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$162K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brunn Carsten made?
Brunn Carsten has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Brunn Carsten trade?
Brunn Carsten has filed SEC Form 4 disclosures for 1 company, including RNAC.
When was Brunn Carsten's most recent SEC Form 4 filing?
Brunn Carsten's most recent SEC Form 4 filing on Tracefour is dated Jan 8, 2026.
What is Brunn Carsten's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brunn Carsten is listed as President and CEO.
What is Brunn Carsten's total buy and sell value in the current window?
Inside the rolling retention window, Brunn Carsten bought $0 and sold $162K based on SEC Form 4 filings.
What was Brunn Carsten's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,766 RNAC shares on 2026-01-06, worth $162K, per SEC Form 4 filings.